000 01485 a2200409 4500
005 20250512081234.0
264 0 _c19860121
008 198601s 0 0 eng d
022 _a0022-3042
024 7 _a10.1111/j.1471-4159.1986.tb12933.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGrome, J J
245 0 0 _aLocal cerebral glucose utilisation following indoleamine- and piperazine-containing 5-hydroxytryptamine agonists.
_h[electronic resource]
260 _bJournal of neurochemistry
_cJan 1986
300 _a117-24 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAutoradiography
650 0 4 _aBehavior, Animal
_xdrug effects
650 0 4 _aBrain
_xdrug effects
650 0 4 _aDeoxyglucose
_xmetabolism
650 0 4 _aGlucose
_xmetabolism
650 0 4 _aGuinea Pigs
650 0 4 _aLysergic Acid Diethylamide
_xpharmacology
650 0 4 _aMale
650 0 4 _aMethoxydimethyltryptamines
_xpharmacology
650 0 4 _aPyrazines
_xpharmacology
650 0 4 _aQuinolines
_xpharmacology
650 0 4 _aQuipazine
_xpharmacology
650 0 4 _aRats
650 0 4 _aRats, Inbred Strains
650 0 4 _aReceptors, Serotonin
_xmetabolism
650 0 4 _aSerotonin
_xanalogs & derivatives
700 1 _aHarper, A M
773 0 _tJournal of neurochemistry
_gvol. 46
_gno. 1
_gp. 117-24
856 4 0 _uhttps://doi.org/10.1111/j.1471-4159.1986.tb12933.x
_zAvailable from publisher's website
999 _c3945958
_d3945958